
Alzheon
Alzheon: A Framingham-based biopharmaceutical firm developing treatments for neurological disorders.
- 11
- Series E
Founded in 2013, Alzheon is a clinical-stage biopharmaceutical company headquartered in Framingham, Massachusetts. The company's core mission is to develop innovative treatments for Alzheimer's disease and other neurological and psychiatric disorders. Alzheon leverages precision medicine to create solutions that can significantly slow or halt the progression of these diseases. Their leading product, ALZ-801, is an oral anti-amyloid treatment currently in Phase testing, aimed at preventing the onset of clinical symptoms and preserving future memories.
Key figures in Alzheon include CEO Martin Tolar, MD, PhD, and Executive Chairman Neil Flanzraich. The company has garnered attention for its significant advancements in Alzheimer's research, particularly with ALZ-801. By focusing on well-tolerated treatments based on extensive research, Alzheon has made impactful strides in the pharmaceutical industry, offering hope to millions affected by neurological disorders. Their work has positioned them as a promising player in the fight against Alzheimer's disease.
Similar Companies

Allyx Therapeutics
allyxthera.com

Aztherapies

Alzeca Biosciences
alzeca.com
Intellect Neurosciences
intellectns.com

Alkeus Pharmaceuticals
alkeus.com

Alto Neuroscience

Alector
alector.com
Sonexa Therapeutics

NeuroGenetic Pharmaceuticals

Oscillo Biosciences
Filana Therapeutics
filanatx.com

Alsp

Neuraly
neuralymed.com

AgeneBio
agenebio.com

Cognito Therapeutics
cognitotx.com
Quick Facts
Who are Alzheon's competitors?
Companies similar to Alzheon include Allyx Therapeutics, Aztherapies, Alzeca Biosciences and Intellect Neurosciences.
When was Alzheon founded?
Alzheon was founded in 2013.
Where is Alzheon's headquarters located?
Alzheon's headquarters is located in Framingham, MA, US.
How much disclosed funding has Alzheon raised?
As of the latest available date, Alzheon has disclosed funding of $452M (USD). Undisclosed round amounts are excluded.
How many employees does Alzheon have?
Alzheon has 11 employees as of Feb 5, 2024.
Classification
- Ownership
- Technology
- Geographic Exposure
- United States
- Customer
- Main Product
- NAICS
- 320000Manufacturing
- 325400Pharmaceutical and Medicine Manufacturing
- 325000Chemical Manufacturing
- 325410Pharmaceutical and Medicine Manufacturing
- 325412Pharmaceutical Preparation Manufacturing
- SIC
- 2800Chemicals And Allied Products
- 2830Drugs
- 2834Pharmaceutical Preparations
- ISIC
- 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 19 more industry codes
- NAICS
- 540000Professional, Scientific, and Technical Services
- 541310Architectural Services
- 541714Research and Development in Biotechnology (except Nanobiotechnology)
- 620000Health Care and Social Assistance
- 541000Professional, Scientific, and Technical Services
- 623000Nursing and Residential Care Facilities
- 541300Architectural, Engineering, and Related Services
- 541700Scientific Research and Development Services
- 541710Research and Development in the Physical, Engineering, and Life Sciences
- SIC
- 8710Engineering, Architectural, And Surveying Services
- 8712Architectural Services
- 4000Railroad Transportation
- 8000Health Services
- 8700Engineering, Accounting, Research, Management, And Related Services
- 8040Offices And Clinics Of Other Health Practitioners
- 8730Research, Development, And Testing Services
- 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
- 8731Commercial Physical and Biological Research
- ISIC
- 7110Architectural and engineering activities and related technical consultancy